← Back to Search

Device

All Subjects for Arrhythmia (RHAPSODY Trial)

N/A
Recruiting
Led By Thomas H McElderry, MD
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day- procedure
Awards & highlights
No Placebo-Only Group

Summary

The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.

Eligible Conditions
  • Arrhythmia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day- procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day- procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Physician Feedback on Software Performance

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All SubjectsExperimental Treatment1 Intervention
All subjects are included in this cohort and are treated with the Rhythmia Mapping System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rhythmia Mapping System
2015
N/A
~20

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
741 Previous Clinical Trials
856,801 Total Patients Enrolled
13 Trials studying Arrhythmia
4,736 Patients Enrolled for Arrhythmia
Thomas H McElderry, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
~4 spots leftby Mar 2025